Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(71.4%)
Phase 4
2(28.6%)
7Total
N/A(5)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT06080139Not ApplicableCompleted

Supporting Refugee Parenting Community and Family Mental Health in Tijuana

Role: collaborator

NCT03762187Not ApplicableCompleted

A Brief Affirmation Intervention on HIV-related Distress and Positive Living in Lesotho

Role: collaborator

NCT02862925Not ApplicableCompleted

Introducing Fetal Scalp Stimulation as an Adjunct to Intermittent Auscultation in Low-Resource Settings.

Role: collaborator

NCT00298051Not ApplicableCompleted

Umbilical Cord Clamping and Infant Iron Status

Role: collaborator

NCT02236455Not ApplicableCompleted

Effects of Complementary Therapies Delivered Via Mobile Technologies

Role: collaborator

NCT00277862Phase 4Completed

Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis Genotype 4

Role: collaborator

NCT00241618Phase 4Completed

Timing and Duration of Acute Hepatitis C Treatment

Role: collaborator

All 7 trials loaded